Tagoor Brochure 29.19.19.pdf - CPhI Online
-
Upload
khangminh22 -
Category
Documents
-
view
2 -
download
0
Transcript of Tagoor Brochure 29.19.19.pdf - CPhI Online
TAGOOR LABORATORIES PVT LTD
TAGOOR
Our Priorities:
TAGOOR
The prestigious GROUP was established in the year 2005. Over the years, the group has expanded and diversified into a variety of businesses, namely:
Manufacturing of bulk drugs and their intermediates
Manufacturing of Fish and Cattle Feed with a capacity of 200 metric tons per day.
Rice Bran Oil Extraction plant with a capacity of 250 Metric tons per day.
Hatcheries of Pangasius Fish which cater to more than 10000 farmers in southern states of India
Fish and Prawn Cultures which spread over 1700 Acres of land.
Team work guided by ‘Empathy' and ‘Dynamism', that provide guidance for current behaviour and inspiration for future actions
Address customer needs by supplying high-quality material.
Game-changing inventory of finished products being demand ready round the clock
Owning the power to enable and help customers ensure that products are delivered when needed, where needed
Offering Innovative Product supply at affordable prices.
Round the clock availability to the customers offering care, innovative solutions and help them succeed.
These priorities and principles make GROUP a supplier of choice both in the domestic as well as global markets. Both the API Plants (Tagoor Chemicals and Tagoor Laboratories) are of ISO 9001, 14001 & GMP certified companies. The combined facility is well established with 135 reactors ranging from 1 kl to 15 kl with total capacity of 650 KL.
l
l
l
l
l
R
ACTIVE PHARMACEUTICAL INGREDIENTS
1 Pantoprazole Sodium 164579-32-2 Anti-ulcerSesqui hydrate
2 Omeprazole 73590-58-6 Anti-ulcer
3 Esomeprazole 217087-09-7 Anti-ulcerMagnesium trihydrate
4 Domperidone 57808-66-9 Anti-emetic
5 Domperidone Maleate 99497-03-7 Anti-emetic
6 TerbinafineHCL 78628-80-5 Anti-fungal
7 Loratadine 79794-75-5 Anti-allergic
Structure S.No. Name of the Product CAS No. Therpatic Cat.
ADVANCED INTERMEDIATES
1 2-Chloromethyl-3, 72830-09-2 Pantoprazole4-DimethoxypyridineHCL (Panto Chloro)
2 5-Difluoromethoxy- 97963-62-7 Pantoprazole2-mercapto-1-H-Benzimidazole
3 1-(3-Chloropropyl)-1, 62780-89-6 Domperidone3- dihydro-2H-Benzimidazol -2-One (DOM II)
4 5- Chloro-1-piperidine- 53786-28-0 Domperidone4-yl-1, 3-dihydro -2H-benzimidazol -2-one (DOM-IX)
5 N-Methyl-1- 65473-13-4 Terbinafinemethylamine HCL HCL
6 N-Methyl-1-naphthalene 14489-75-9 Terbinafine methylamine (Base) HCL
naphthalene
Structure S.No. CAS No. Related API Name of the Product
ADVANCED INTERMEDIATES
7 3, 5-dimethyl- 14248-66-9 Omeprazole
4-nitropyridine-1 and
-oxide (Ome Nitro) Esomeprazole
8 2-Hydroxymethyl -3, 86604-78-6 Omeprazole
5-Dimethyl, 4-Methoxy and
Pyridine Esomeprazole
(Omehydroxy Base)
9 2-Chloromethyl-3, 86604-75-3 Omeprazole
5-dimethyl-4- and
methoxypyridine Esomeprazole
HCL (OmeChloro)
10 5-Methoxy-2 73590-85-9 Esomeprazole[[(4-methoxy -3,5 dimethyl-2-methylpyridyl)
1 H- thio benzimidazole
(Omesulfide)
11 2-N-Butyl-1, 3-Diazaspiro 151257-01-1 Irbesartan
(4, 4’) Non-1-En-4-One
Hydrochloride
Spiro Compound (IRBI)
Structure S.No. Name of the Product CAS No. Related API
ADVANCED INTERMEDIATES
12 Dibenzosuberone 1210-35-1 Amitriptyline
Cyclobenzatrine
Nortriptyline
13 Dibenzosuberenone 2222-33-5 Amitriptyline
Cyproheptadine
Nortriptyline
14 Dihydro-N, N-dimethyl-3, 37743-18-3 Loperamide
3-diphenyl-2(3H)-
furaniminium bromide
15 4-(4-Chlorophenyl)- 39512-49-7 Haloperidol
4-hydroxy piperidine Loperamide
(PCP) HCL
16 1-(2,3-Dichlorophenyl) 119532-26-2 Aripiprazola
Piperazine HCL Cariprazine
17 3, 4-Dihydro-7- 129722-34-5 Aripiprazola
(4-bromobutoxy)- Brexpiprazola
2(1H)-quinolinone
Structure S.No. Name of the Product CAS No. Related API
PIPERIDINE AND PIPERIDONE INTERMEDIATES
1. N-Methyl-4-chloropiperidine 5570-77-4
2. N-Methyl-4-chloropiperidine Hcl 5382-23-0
3. N-Methyl-4-piperidone 1445-73-4 Domperidone, Haloperidol
4. N-Isobutyl-4-piperidone 72544-16-2 Rifabutin
5. N-Methyl-4-hydroxy-piperidine 106-52-5 Drug intermediate
6. N-Carbethoxy-4-piperidone 29976-53-2 Domperidone
7. Ethyl 4-hydroxypiperidine-1-carboxylate 65214-82-6 Bepotastine besilate
8. Ethyl 4-aminopiperidine-1-carboxylate 58859-46-4 Domperidone
9. N-Methyl-1,2,3,6-tetrahydropyridine HCl 73107-26-3 Common Scaffold
10. 4-Hydroxy piperidine 5382-16-1 Bepotastine Rupatidine
11. 1-Benzy-4-piperidone 3612-20-2 Drug intermediate
12. 1-Benzyl-4-chloropiperidine 67848-71-9 Drug intermediate
13. 1-Benzylpiperidin-4-ol 4727-72-4 Drug intermediate
14. N-tert-Butoxycarbonyl-4-piperidone 79099-07-3 Drug intermediate
15. N-tert-Butoxycarbonyl-4-hydroxy piperidine 109384-19-2 Crizotinib
16. 4-Piperidinopiperidine 4897-50-1 Irinotecan
17. 4-Piperidinopiperidine di HCl 172281-92-4 Irinotecan
18. 1-Methyl-4-(4-piperidinyl) piperazine 53617-36-0 Brigatinib
19. 1-Methyl-4-(4-piperidinyl) piperazine di HCl 1219979-73-3 Brigatinib
20. 4-Aminopiperidine 13035-19-3 Drug intermediate
21. 4-N-BOC-Aminopiperidine 73874-95-0 Drug intermediate
22. 1-Methylpiperidin-4-amine 41838-46-4 Drug intermediate
23. 4-Phenylpiperidine 771-99-3 Drug intermediate
24. 4-(Benzhydryloxy)piperidine 58258-01-8 Drug intermediate
25. 4-(Benzhydryloxy)piperidine HCl 132-18-3 Drug intermediate
26. 1-(3-Methoxypropyl)piperidin-4-one 16771-85-0 Prucalopride
27. N-[(4-Fluorophenyl)methyl]-1-methyl- 359878-47-0 Pimavanserin4-piperidinamine
28. 3,5-Dimethylpiperidine (3,5-Lupetidine) 35794-11-7 Drug intermediate
besilate,
S.No. CAS No. ApplicationChemical Name
Loratadine, Ketotifene,Cyproheptadine HCl, Aclaftadine
About Group
Tagoor Laboratories Pvt Ltd & Tagoor Chemicals Pvt Ltd
Facilities Available:
l
l
l
l
l
l
The success of TAGOOR GROUP as a API & bulk drug intermediate manufacturer paved the way to upgrade its chemical entity. They have built 2 state of the art facilities with upgraded and environmental friendly machinery at West Godavari district of Andhra Pradesh, India popularly called.
The main objective of the companies is to produce APIs and key intermediates with world class quality at highly competitive prices. The company has highly strengthened Production, QC, QA and R&D team for the production of bulk drugs and their intermediates.
The industry is more focused towards the policy of “RRR” (refers Reduce, Reuse and Recycle) briefly Reducing the quantity of media and reagents used in the chemical transformations, Reusing and Recycling the solvents and other materials for the subsequent processes without affecting the quality of finished goods.
The greatest strength is to isolate valuable by- products which are generated during the process of making bulk drugs and intermediates in independently designed production blocks. The concept is economically attractive and environment friendly in the view of reducing waste.
The company uses ground-breaking, pioneering equipment necessary for diverse chemical transformations such as:
Oxidation reactions.
Halogenations i.e. Bromination and Chlorination.
Hydrogenations and reductive aminations up to pressure 10 kg/cm2.
Highly acidic reactions such as nitration and chloro sulfonation.
High vacuum distillations are performed up to 250°C and 1 Torr.
The facility is designed in such a way that the reactions can be performed at the temperatures ranging from - 15°C to 250°C.
e-mail: [email protected]
Admin Office:Plot No. 99 & 100, S.V. Co-Operative Industrial Estate,IDA Jeedimetla, Hyderabad - 500055,Telangana State, India.Ph: +91 91009 90067 (wechat)
Plant:Survey No. 29,Tupakulagudem, Pochavaram Panchayat, Tallapudi Mandal, West Godavari Dist. Andhra Pradesh - 534341, India.
webiste: www.tagoorlabs.com